Prime Medicine (PRME) Invested Capital (2021 - 2025)
Historic Invested Capital for Prime Medicine (PRME) over the last 5 years, with Q3 2025 value amounting to $161.8 million.
- Prime Medicine's Invested Capital fell 1460.81% to $161.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.8 million, marking a year-over-year decrease of 1460.81%. This contributed to the annual value of $153.1 million for FY2024, which is 1508.82% up from last year.
- According to the latest figures from Q3 2025, Prime Medicine's Invested Capital is $161.8 million, which was down 1460.81% from $60.9 million recorded in Q2 2025.
- In the past 5 years, Prime Medicine's Invested Capital registered a high of $316.3 million during Q4 2022, and its lowest value of -$223.1 million during Q3 2022.
- Over the past 5 years, Prime Medicine's median Invested Capital value was $153.1 million (recorded in 2024), while the average stood at $84.7 million.
- Examining YoY changes over the last 5 years, Prime Medicine's Invested Capital showed a top increase of 30242.58% in 2022 and a maximum decrease of 13628.55% in 2022.
- Over the past 5 years, Prime Medicine's Invested Capital (Quarter) stood at -$156.2 million in 2021, then soared by 302.43% to $316.3 million in 2022, then crashed by 57.92% to $133.1 million in 2023, then rose by 15.09% to $153.1 million in 2024, then rose by 5.66% to $161.8 million in 2025.
- Its last three reported values are $161.8 million in Q3 2025, $60.9 million for Q2 2025, and $106.9 million during Q1 2025.